Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
If you miss a tablet, the missed dose should be skipped, and you should restart taking it as normal the following day
The SELECT trial demonstrated that semaglutide 2.4 mg reduced major adverse cardiovascular events (heart attack, stroke, and cardiovascular death) by 20% in adults with overweight or obesity and established heart disease (Lincoff et al., SELECT trial, New England Journal of Medicine , 2023)
Semaglutide is contraindicated in patients with: Personal or family history of medullary thyroid carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) Common Adverse Effects According to clinical trial data, gastrointestinal effects are most frequently reported: nausea, vomiting, diarrhea, constipation, and abdominal discomfort
For prior authorization to be approved for a GLP-1 medication, we will need to provide specific information about your medical condition and treatment history
Due to potential risks of medullary thyroid carcinoma and multiple endocrine neoplasia, its not recommended for individuals with a personal or family history of these conditions [45]
There's a big difference between honest, evidence-based recommendations and paid promotion, and unfortunately, the two aren't always easy to tell apart
